ArticleClinicoEconomics and outcomes research : CEOR2025

Cost-Effectiveness Analysis for Managing Diabetic Foot Ulcer (DFU) in USA: Platelet-Rich Plasma (PRP) vs Standard of Care (SoC).

Salvatore Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.